| Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung B McCullar, M Pandey, G Yaghmour, F Hare, K Patel, M Stein, R Feldman, ... Breast cancer research and treatment 158, 195-202, 2016 | 39 | 2016 |
| Role of genomic instability in immunotherapy with checkpoint inhibitors G Yaghmour, M Pandey, C Ireland, K Patel, S Nunnery, D Powell, S Baum, ... Anticancer research 36 (8), 4033-4038, 2016 | 33 | 2016 |
| Ibrutinib has some activity in Richter’s syndrome S Giri, A Hahn, G Yaghmour, MG Martin Blood cancer journal 5 (1), e277-e277, 2015 | 28 | 2015 |
| Early mortality in acute myeloid leukemia A Hahn, S Giri, G Yaghmour, MG Martin Leukemia research 39 (5), 505-509, 2015 | 24 | 2015 |
| Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia AS Advani, A Moseley, KM O’Dwyer, BL Wood, J Park, M Wieduwilt, ... Blood advances 7 (7), 1279-1285, 2023 | 18 | 2023 |
| Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse‐free survival rates as allogeneic hematopoietic stem cell transplantation in … J Chang, D Douer, I Aldoss, G Vahdani, AR Jeong, Z Ghaznavi, S Zhang, ... Cancer Medicine 8 (6), 2832-2839, 2019 | 18 | 2019 |
| Genomic alterations in neuroendocrine cancers of the ovary G Yaghmour, P Prouet, E Wiedower, OH Jamy, R Feldman, JC Chandler, ... Journal of Ovarian Research 9, 1-5, 2016 | 18 | 2016 |
| The presence of Philadelphia chromosome does not confer poor prognosis in adult pre‐B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era–a surveillance … IJ Igwe, D Yang, A Merchant, N Merin, G Yaghmour, K Kelly, G Ramsingh British journal of haematology 179 (4), 618-626, 2017 | 17 | 2017 |
| Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable‐risk acute myeloid leukemia S Arslan, J Zhang, P Dhakal, J Moran, N Naidoo, J Lombardi, V Pullarkat, ... American journal of hematology 96 (3), E59-E63, 2021 | 14 | 2021 |
| The role of FLT3 inhibitors as maintenance therapy following hematopoietic stem cell transplant GX Li, L Wang, B Yaghmour, G Ramsingh, G Yaghmour Leukemia research reports 10, 26-36, 2018 | 14 | 2018 |
| Population-based analysis of the clinical features of primary small cell carcinoma of the ovary O Jamy, G Yaghmour, F Hare, MG Martin Anticancer research 35 (5), 3091-3095, 2015 | 14 | 2015 |
| A phase 2 study of dasatinib, prednisone, and blinatumomab for older patients with Philadelphia-chromosome (Ph) positive or Ph-like acute lymphoblastic leukemia (ALL)(with … A Advani, A Moseley, K O'Dwyer, B Wood, JH Park, M Wieduwilt, ... Blood 138, 3397, 2021 | 13 | 2021 |
| How center volumes affect early outcomes in acute myeloid leukemia AW Hahn, O Jamy, S Nunnery, G Yaghmour, S Giri, R Pathak, MG Martin Clinical Lymphoma Myeloma and Leukemia 15 (11), 646-654, 2015 | 13 | 2015 |
| Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia N Punwani, N Merin, A Mohrbacher, G Yaghmour, A Sano, L Ramezani, ... Leukemia research reports 9, 18-20, 2018 | 11 | 2018 |
| Randomized phase II study to assess the role of nivolumab as single agent to eliminate minimal residual disease and maintain remission in acute myelogenous leukemia (AML … H Liu, E Sharon, TG Karrison, Y Zha, N Fulton, H Streicher, K Sweet, ... Blood 140 (Supplement 1), 1716-1719, 2022 | 9 | 2022 |
| Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post‐haploidentical allogeneic stem cell transplant. A Martynova, A Nael, C O'Neill, G Ramsingh, A Merchant, B Yaghmour, ... British Journal of Haematology 186 (5), 2019 | 8 | 2019 |
| Comorbidities drive outcomes for both malignancy-associated and non–malignancy-associated hemophagocytic syndrome B Johnson, S Giri, SE Nunnery, E Wiedower, O Jamy, G Yaghmour, ... Clinical Lymphoma Myeloma and Leukemia 16 (4), 230-236, 2016 | 8 | 2016 |
| Drug-induced aseptic meningitis associated with intrathecal trastuzumab CW Freyer, G Yaghmour, K Jennings, V Dhanapal Journal of Pharmacy Technology 30 (2), 43-47, 2014 | 8 | 2014 |
| A case of recurrent pregnancy-induced adult onset familial hemophagocytic lymphohistiocytosis LY Wang, J Hu, G Ramsingh, B Theodory, B Yaghmour, M Vergara-Lluri, ... World Journal of Oncology 9 (4), 123, 2018 | 7 | 2018 |
| Addition of rituximab to chemotherapy reduced the rate of surgery for gastric-DLBCL without increasing early mortality P Prouet, S Giri, E Wiedower, A Fintel, G Yaghmour, EP Lamb, J Deneve, ... Anticancer Research 37 (2), 813-817, 2017 | 6 | 2017 |
